Handelsbanken Fonder’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Buy
34,500
+2,200
+7% +$67K ﹤0.01% 1004
2026
Q1
$802K Hold
32,300
﹤0.01% 1135
2025
Q4
$821K Buy
32,300
+8,500
+36% +$190K ﹤0.01% 1126
2025
Q3
$384K Hold
23,800
﹤0.01% 1366
2025
Q2
$381K Buy
23,800
+2,900
+14% +$43.9K ﹤0.01% 1355
2025
Q1
$357K Hold
20,900
﹤0.01% 1352
2024
Q4
$518K Hold
20,900
﹤0.01% 1270
2024
Q3
$596K Buy
20,900
+4,700
+29% +$139K ﹤0.01% 1174
2024
Q2
$428K Buy
16,200
+4,400
+37% +$125K ﹤0.01% 1219
2024
Q1
$381K Hold
11,800
﹤0.01% 1287
2023
Q4
$497K Buy
11,800
+2,900
+33% +$107K ﹤0.01% 1153
2023
Q3
$342K Buy
+8,900
New +$201K ﹤0.01% 1253
2021
Q1
Sell
-7,100
Closed -$328K 1572
2020
Q4
$328K Buy
+7,100
New +$328K ﹤0.01% 1363

Other funds holding IMVT